IL145736A0 - Combinations of gaba analogs and tricyclic compounds to treat depression - Google Patents

Combinations of gaba analogs and tricyclic compounds to treat depression

Info

Publication number
IL145736A0
IL145736A0 IL14573600A IL14573600A IL145736A0 IL 145736 A0 IL145736 A0 IL 145736A0 IL 14573600 A IL14573600 A IL 14573600A IL 14573600 A IL14573600 A IL 14573600A IL 145736 A0 IL145736 A0 IL 145736A0
Authority
IL
Israel
Prior art keywords
combinations
tricyclic compounds
treat depression
gaba analogs
gaba
Prior art date
Application number
IL14573600A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL145736A0 publication Critical patent/IL145736A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14573600A 1999-04-09 2000-02-16 Combinations of gaba analogs and tricyclic compounds to treat depression IL145736A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12857199P 1999-04-09 1999-04-09
PCT/US2000/003983 WO2000061234A1 (fr) 1999-04-09 2000-02-16 Combinaisons d'analogues d'acide glutamique et d'acide gamma-aminobutyrique (gaba) et de composes tricycliques permettant de traiter la depression

Publications (1)

Publication Number Publication Date
IL145736A0 true IL145736A0 (en) 2002-07-25

Family

ID=22435960

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14573600A IL145736A0 (en) 1999-04-09 2000-02-16 Combinations of gaba analogs and tricyclic compounds to treat depression

Country Status (11)

Country Link
EP (1) EP1180058A1 (fr)
JP (1) JP2002541224A (fr)
KR (1) KR20010108466A (fr)
AU (1) AU3492900A (fr)
CA (1) CA2367494A1 (fr)
HU (1) HUP0200733A3 (fr)
IL (1) IL145736A0 (fr)
NZ (1) NZ514401A (fr)
TR (1) TR200102850T2 (fr)
WO (1) WO2000061234A1 (fr)
ZA (1) ZA200108259B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003167A1 (fr) 1996-07-24 1998-01-29 Warner-Lambert Company Isobutylgaba et ses derives utilises pour le traitement de la douleur
CA2473536A1 (fr) * 2002-01-16 2003-07-31 Endo Pharmaceuticals, Inc. Composition pharmaceutique et methode de traitement de troubles du systeme nerveux central
RU2006107534A (ru) * 2003-09-12 2007-09-20 Уорнер-Ламберт Компани Ллс (Us) Комбинация, включающая альфа-2-дельта-лиганд анд и ssri и/или snri, для лечения депрессии и тревожного расстройства
RU2320369C2 (ru) * 2003-09-12 2008-03-27 Пфайзер Инк. Комбинации, содержащие альфа-2-дельта лиганды и ингибиторы обратного захвата серотонина/норадреналина

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2410821A1 (de) * 1974-03-07 1975-09-18 Hoechst Ag Pharmazeutische kombinationspraeparate mit psychotroper wirkung und verfahren zu ihrer herstellung
FR2453643A2 (fr) * 1977-06-24 1980-11-07 Synthelabo Compositions pharmaceutiques actives sur le systeme nerveux central
US5025035A (en) * 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression
AU9137091A (en) * 1990-11-27 1992-06-25 Northwestern University Gaba and l-glutamic acid analogs for antiseizure treatment
EP0726073A3 (fr) * 1995-02-10 1998-07-08 Eduardo Samuel Bleiweiss Compositions pharmaceutique contenant au moins un composé choisi parmi le haloperidol, imipramine et le trifluoroperazine

Also Published As

Publication number Publication date
TR200102850T2 (tr) 2002-03-21
HUP0200733A3 (en) 2003-04-28
AU3492900A (en) 2000-11-14
JP2002541224A (ja) 2002-12-03
WO2000061234A1 (fr) 2000-10-19
NZ514401A (en) 2003-10-31
HUP0200733A2 (hu) 2002-07-29
KR20010108466A (ko) 2001-12-07
CA2367494A1 (fr) 2000-10-19
ZA200108259B (en) 2003-03-26
EP1180058A1 (fr) 2002-02-20

Similar Documents

Publication Publication Date Title
EP1005330A4 (fr) Procedes et compositions permettant de cibler des composes vers des muscles
HUP9900065A3 (en) Use of cgmp-phosphodiesterase inhibitors to treat impotence
IL158420A0 (en) Use of follistatin to increase muscle mass
ZA982020B (en) Treatment of effluent streams
IL147748A0 (en) Use of etodolac to treat cancer
IL144926A0 (en) Distribution of calls to inquiry centers
EP1235785A4 (fr) Nouveaux composes utiles pour traiter le diabete et les pathologies associees
IL145736A0 (en) Combinations of gaba analogs and tricyclic compounds to treat depression
IL146237A0 (en) Autotaxin variants and uses to treat diseases of metabolism
GB2353217B (en) Use of ribose to treat fibromyalgia
GB9923951D0 (en) Treatment of gas mixture
HUP0002896A3 (en) Use of polyelectrolytes as sequestering agents
GB0205307D0 (en) Initiation of oestrus
TW469837U (en) Improved structure of magnetically-controlled flywheel for exercise bicycle
TW431182U (en) Improved structure of massaging wheel
TW481990U (en) Structure of massage pedal
IL141880A0 (en) Treatment of depression
TW410639U (en) Improved structure of exercise wheel
TW408753U (en) Improved pedal fastening structure of bicycle
AU6191201A (en) Treatment of effluent
TW441356U (en) Structure of saddle-type massage pad
TW428489U (en) Structure of chess set
TW462310U (en) Improved structure of turning wheel for game device
TW410644U (en) Improved structure of exercise wheel
TW568132U (en) Improved structure of spatula